BACKGROUND: To examine the risk of smoking on histopathologically-confirmed moderate- and high-grade prostate cancer. MATERIALS AND METHODS: A population-based case-control study was conducted in Melbourne, Sydney and Perth between 1994 and 1998 in men aged below 70 years. Cases were recruited from cancer registries and controls were selected from electoral registers. 1498 cases and 1434 controls were interviewed and a detailed smoking history obtained. Data were analyzed by unconditional logistic regression, adjusting for age, study center, year of recruitment, family history and country of birth. RESULTS: The odds ratios (OR) were 1.02 (0.85-1.22) for former smoking and 0.82 (0.65-1.05) for current smoking. The respective ORs were 0.95 (0.78-1.15) and 0.76 (0.59-0.99) for moderate grade tumors, and 1.28 (0.96-1.70) and 1.00 (0.67-1.47) for high-grade tumors (P = 0.2 for test that ORs of the two grades were identical). There was no evidence of a dose-response effect for duration of smoking, amount smoked daily, pack-years of smoking and years since quitting and most ORs for these variables were close to unity. CONCLUSIONS: Smoking was not associated with the incidence of prostate cancer. The widths and upper limits of the confidence intervals for the effects of current and former smoking were consistent with weak effects at most.
BACKGROUND: To examine the risk of smoking on histopathologically-confirmed moderate- and high-grade prostate cancer. MATERIALS AND METHODS: A population-based case-control study was conducted in Melbourne, Sydney and Perth between 1994 and 1998 in men aged below 70 years. Cases were recruited from cancer registries and controls were selected from electoral registers. 1498 cases and 1434 controls were interviewed and a detailed smoking history obtained. Data were analyzed by unconditional logistic regression, adjusting for age, study center, year of recruitment, family history and country of birth. RESULTS: The odds ratios (OR) were 1.02 (0.85-1.22) for former smoking and 0.82 (0.65-1.05) for current smoking. The respective ORs were 0.95 (0.78-1.15) and 0.76 (0.59-0.99) for moderate grade tumors, and 1.28 (0.96-1.70) and 1.00 (0.67-1.47) for high-grade tumors (P = 0.2 for test that ORs of the two grades were identical). There was no evidence of a dose-response effect for duration of smoking, amount smoked daily, pack-years of smoking and years since quitting and most ORs for these variables were close to unity. CONCLUSIONS: Smoking was not associated with the incidence of prostate cancer. The widths and upper limits of the confidence intervals for the effects of current and former smoking were consistent with weak effects at most.
Authors: Robert J Macinnis; Antonis C Antoniou; Rosalind A Eeles; Gianluca Severi; Ali Amin Al Olama; Lesley McGuffog; Zsofia Kote-Jarai; Michelle Guy; Lynne T O'Brien; Amanda L Hall; Rosemary A Wilkinson; Emma Sawyer; Audrey T Ardern-Jones; David P Dearnaley; Alan Horwich; Vincent S Khoo; Christopher C Parker; Robert A Huddart; Nicholas Van As; Margaret R McCredie; Dallas R English; Graham G Giles; John L Hopper; Douglas F Easton Journal: Genet Epidemiol Date: 2011-07-18 Impact factor: 2.135
Authors: Robert J MacInnis; Daniel F Schmidt; Enes Makalic; Gianluca Severi; Liesel M FitzGerald; Matthias Reumann; Miroslaw K Kapuscinski; Adam Kowalczyk; Zeyu Zhou; Benjamin Goudey; Guoqi Qian; Quang M Bui; Daniel J Park; Adam Freeman; Melissa C Southey; Ali Amin Al Olama; Zsofia Kote-Jarai; Rosalind A Eeles; John L Hopper; Graham G Giles Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-08-18 Impact factor: 4.254
Authors: G Severi; B A Shannon; H N Hoang; L Baglietto; D R English; J L Hopper; J Pedersen; M C Southey; R Sinclair; R J Cohen; G G Giles Journal: Br J Cancer Date: 2010-07-06 Impact factor: 7.640
Authors: Rosalind A Eeles; Zsofia Kote-Jarai; Ali Amin Al Olama; Graham G Giles; Michelle Guy; Gianluca Severi; Kenneth Muir; John L Hopper; Brian E Henderson; Christopher A Haiman; Johanna Schleutker; Freddie C Hamdy; David E Neal; Jenny L Donovan; Janet L Stanford; Elaine A Ostrander; Sue A Ingles; Esther M John; Stephen N Thibodeau; Daniel Schaid; Jong Y Park; Amanda Spurdle; Judith Clements; Joanne L Dickinson; Christiane Maier; Walther Vogel; Thilo Dörk; Timothy R Rebbeck; Kathleen A Cooney; Lisa Cannon-Albright; Pierre O Chappuis; Pierre Hutter; Maurice Zeegers; Radka Kaneva; Hong-Wei Zhang; Yong-Jie Lu; William D Foulkes; Dallas R English; Daniel A Leongamornlert; Malgorzata Tymrakiewicz; Jonathan Morrison; Audrey T Ardern-Jones; Amanda L Hall; Lynne T O'Brien; Rosemary A Wilkinson; Edward J Saunders; Elizabeth C Page; Emma J Sawyer; Stephen M Edwards; David P Dearnaley; Alan Horwich; Robert A Huddart; Vincent S Khoo; Christopher C Parker; Nicholas Van As; Christopher J Woodhouse; Alan Thompson; Tim Christmas; Chris Ogden; Colin S Cooper; Melissa C Southey; Artitaya Lophatananon; Jo-Fen Liu; Laurence N Kolonel; Loic Le Marchand; Tiina Wahlfors; Teuvo L Tammela; Anssi Auvinen; Sarah J Lewis; Angela Cox; Liesel M FitzGerald; Joseph S Koopmeiners; Danielle M Karyadi; Erika M Kwon; Mariana C Stern; Roman Corral; Amit D Joshi; Ahva Shahabi; Shannon K McDonnell; Thomas A Sellers; Julio Pow-Sang; Suzanne Chambers; Joanne Aitken; R A Frank Gardiner; Jyotsna Batra; Mary Anne Kedda; Felicity Lose; Andrea Polanowski; Briony Patterson; Jürgen Serth; Andreas Meyer; Manuel Luedeke; Klara Stefflova; Anna M Ray; Ethan M Lange; Jim Farnham; Humera Khan; Chavdar Slavov; Atanaska Mitkova; Guangwen Cao; Douglas F Easton Journal: Nat Genet Date: 2009-09-20 Impact factor: 38.330
Authors: Chol-Hee Jung; Ee Ming Wong; Liesel M FitzGerald; JiHoon E Joo; Jodee A Gould; Vivien Vasic; Julie K Bassett; Neil O'Callaghan; Tim Nottle; John Pedersen; Graham G Giles; Melissa C Southey Journal: Lab Invest Date: 2018-01-16 Impact factor: 5.662
Authors: Benjamin A Rybicki; Christine Neslund-Dudas; Cathryn H Bock; Andrew Rundle; Adnan T Savera; James J Yang; Nora L Nock; Deliang Tang Journal: Clin Cancer Res Date: 2008-02-01 Impact factor: 12.531
Authors: Melissa A Yow; Sepehr N Tabrizi; Gianluca Severi; Damien M Bolton; John Pedersen; Anthony Longano; Suzanne M Garland; Melissa C Southey; Graham G Giles Journal: BMC Cancer Date: 2014-08-09 Impact factor: 4.430